Kamada (KMDA) Accounts Payables (2012 - 2026)

Kamada (KMDA) posted quarterly Accounts Payables of $21.9 million for Q1 2026, down 11.73% year-on-year from $24.9 million in Q1 2025, and down 5.61% on a QoQ basis from $23.2 million in Q4 2025.

Kamada (KMDA) Accounts Payables (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Accounts Payables for 15 consecutive years, with $21.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Accounts Payables fell 11.73% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 11.73% YoY) and the FY2025 annual result came in at $23.2 million, down 16.2% from the prior year.
  • Accounts Payables retreated to $21.9 million in Q1 2026 per KMDA's latest filing, from $23.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for KMDA reached as high as $32.9 million in Q4 2022 and fell as low as $26210.0 in Q1 2023.
  • A 5-year average of $19.2 million and a median of $21.9 million in 2026 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2022 — Accounts Payables tumbled 99.84% — and 2024, when it surged 62822.55%.
  • Year by year, Accounts Payables stood at $32.9 million in 2022, then decreased by 24.65% to $24.8 million in 2023, then increased by 11.82% to $27.7 million in 2024, then slipped by 16.2% to $23.2 million in 2025, then decreased by 5.61% to $21.9 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $21.9 million, $23.2 million, and $24.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 4.96 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 2.60 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 507.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.13 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 498.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 1.67 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.75 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 773.00 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 372.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 21.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.94 Mn
Dec 31, 2025 23.24 Mn
Sep 30, 2025 24.88 Mn
Jun 30, 2025 25.08 Mn
Mar 31, 2025 24.85 Mn
Dec 31, 2024 27.74 Mn
Sep 30, 2024 14.79 Mn
Jun 30, 2024 19.53 Mn
Mar 31, 2024 16.49 Mn
Dec 31, 2023 24.80 Mn
Sep 30, 2023 12.81 Mn
Jun 30, 2023 27.97 Mn
Mar 31, 2023 26,210.00
Dec 31, 2022 32.92 Mn
Sep 30, 2022 30,619.00
Jun 30, 2022 17.95 Mn
Mar 31, 2022 11.68 Mn
Dec 31, 2021 25.10 Mn
Sep 30, 2021 19.01 Mn
Jun 30, 2021 17.95 Mn